Sort
21,453 grants matching “tuberculosis”
A New Approach to an Old Problem: Redesigning Latent Tuberculosis Screening and Treatment
$772,216Sara Tartof · Kaiser Foundation Research Institute · R01 · FY2023 · AI
Linking the behavior of individual host cells to their transcriptional signatures
$772,200Lalita Ramakrishnan · University Of Washington · DP1 · FY2012 · MH
Linking the behavior of individual host cells to their transcriptional signatures
$772,200Lalita Ramakrishnan · University Of Washington · DP1 · FY2014 · MH
Linking the behavior of individual host cells to their transcriptional signatures
$772,200Lalita Ramakrishnan · University Of Washington · DP1 · FY2011 · OD
Enhancing cytotoxic lymphocytes in a TB vaccine strategy
$772,170Joanne L. Flynn · University Of Pittsburgh At Pittsburgh · R01 · FY2022 · AI
Lesion-centric imaging and PK-PD of pyrazinamide for TB/HIV co-infection
$771,638Veronique Dartois · Rbhs-New Jersey Medical School · R01 · FY2013 · AI
Task A04 Mouse models for the early evaluation of drug candidates against M.TB
$771,634Linda Monum · Colorado State University · N01 · FY2011 · AI
Combatting natural resistance and persistence in non-TB mycobacterial disease
$771,560Thomas Dick · Rbhs-New Jersey Medical School · R01 · FY2018 · AI
Immunology and Outcomes after HAART in HIV/TB Coinfection
$771,364Gregory P. Bisson · University Of Pennsylvania · R01 · FY2011 · AI
Mapping and modeling host-pathogen interactions in TB latency and reactivation
$771,347Maria Laura Gennaro · Univ Of Med/Dent Of Nj-Nj Medical School · R01 · FY2010 · HL
Identifying TB transmitters in high TB/HIV burdened communities
$771,199Robin Wood · Desmond Tutu Hiv Foundation · R01 · FY2023 · AI
The PHASES Project: Pregnancy and HIV/AIDS-Seeking Equitable Study
$770,869Anne Drapkin Lyerly · Univ Of North Carolina Chapel Hill · R01 · FY2016 · AI
Bacterial Mechanisms and Host Pharmacokinetic Factors that Determine Persistence
$770,673Veronique Dartois · Rbhs-New Jersey Medical School · U19 · FY2020 · AI
Discovery of Phospopantetheinyl Transferse Inhibitors Against Mycobacterium tuberculosis
$770,597Jeffrey Aube · Univ Of North Carolina Chapel Hill · R01 · FY2024 · AI
An RNA Nanosensor for the Diagnosis of Antibiotic Resistance in M. Tuberculosis
$770,594Maha Farhat · Harvard Medical School · R01 · FY2023 · AI
Siderophore Inhibitors for Tuberculosis that Block Mycobactin Biosynthesis
$770,507Courtney C Aldrich · University Of Minnesota · R01 · FY2019 · AI
INTERNATIONAL TRAINING PROGRAM IN EPIDEMIOLOGY OF AIDS
$770,441Columbia University Health Sciences · D43 · FY2002 · TW
A Scalable Platform to Discover Antimicrobials of Ribosomal Origin
$770,174Huimin Zhao · University Of Illinois At Urbana-Champaign · R01 · FY2023 · AI
A Scalable Platform to Discover Antimicrobials of Ribosomal Origin
$770,174Huimin Zhao · University Of Illinois At Urbana-Champaign · R01 · FY2022 · AI
Promoting Adherence to TB Regimens in High-Risk Youth
$770,041Melbourne F Hovell · San Diego State University · R01 · FY2007 · HL
A Multidisciplinary Approach to Understanding TB Latency and Reactivation
$769,928Petros C Karakousis · Johns Hopkins University · R01 · FY2012 · HL
Ontogeny and metabolism of lung alveolar macrophages in tuberculosis
$769,925Lu Huang · Univ Of Arkansas For Med Scis · R01 · FY2024 · AI
Mucosal subunit vaccines against SARS CoV-2
$769,833Purnima Dubey · Ohio State University · R01 · FY2024 · AI
One-carbon metabolism and immune cell function in tuberculosis
$769,821Lanbo Shi · Rutgers Biomedical And Health Sciences · R01 · FY2024 · AI
TUBERCULOSIS ELIMINATION AND LABORATORY
$769,726Greduvel Duran Guzman · Puerto Rico Department Of Health · U52 · FY2009 · PS